Mediclinic International Ltd. Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 6/10/2022)
| Balance Sheet | Total Assets | 7,516,000,000.00 | ROE | – |
| Balance Sheet | Total Equity | 3,526,000,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -179,000,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 375,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 554,000,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.18 | Div. Yield | – |
| Income | Net Income | 135,000,000.00 | P/E | – |
| Income | Shares Outstanding | 755,000,000.00 | P/B | – |
| Income | Total Revenue | 3,618,000,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Mediclinic International Limited is an international private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. The Company is focused on providing acute care, specialist-orientated, multidisciplinary healthcare services. Mediclinic provides a range of hospital-related clinical services throughout its operating platforms. This includes outpatient consultation services and pre-hospital emergency services, hospital-based emergency centers, day case surgery, acute care inpatient services and specialized services. Its support services include laboratory, radiology, and nuclear medicine. It offers services under the brands Mediclinic Southern Africa, Hirslanden and Mediclinic Middle East. Mediclinic Southern Africa hospital services range from routine procedures and medical treatment plans; Hirslanden hospital services range from routine procedures and medical treatment plans, and Mediclinic Middle East offers acute care hospital services.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.mediclinic.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more